Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Your walking pattern may reveal more about anxiety and depression than you think

16

Sep 2026

Your walking pattern may reveal more about anxiety and depression than you think

Researchers used smartphone and wearable accelerometers to examine how everyday movement patterns relate to anxiety and depression symptoms in middle-aged adults. Phone-derived gait states differed with daily symptom scores, while lower wrist movement was linked to greater anxiety in a small subsample, supporting further study of passive movement sensing for mental health monitoring.

Bulimia nervosa linked to structural differences in brain regions

16

Sep 2026

Bulimia nervosa linked to structural differences in brain regions

Researchers at the Icahn School of Medicine at Mount Sinai found that individuals with bulimia nervosa have structural differences in brain regions involved in reward and motivation, as well as social and sensory processing, and that more frequent binge eating is associated with more widespread differences in brain structure, according to research published today in JAMA Psychiatry.

Shatavari may affect more than hormones, and the gut could help explain why

16

Sep 2026

Shatavari may affect more than hormones, and the gut could help explain why

A review in Nutrients examined how bioactive compounds in Asparagus racemosus (Shatavari) may influence cognitive health through the microbiota-gut-brain axis, estrogen-related signaling, neuroinflammation, oxidative stress, and neurotransmitter regulation. Evidence from computational, cellular, animal, and limited human studies suggests several plausible biological pathways, but key questions remain about bioavailability, brain exposure, dosing, and clinical efficacy.

RES-AGE project explores cost-effective ways to strengthen older adults' wellbeing

16

Sep 2026

RES-AGE project explores cost-effective ways to strengthen older adults' wellbeing

How can we develop evidence‑based and cost‑effective ways to strengthen older adults' resilience and mental wellbeing? With just over 1 million euros from the Strategic Research Council, Åbo Akademi University will, over an initial period of three years, examine social, health‑related, psychological and biological factors that promote resilience, with a particular focus on loneliness, stress and health.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.